Live Poll Results — Which pharmaceutical company faced severe backlash for its EpiPen pricing strate
See real-time poll results. Powered by AIPolls.Net.
Pharmaceutical Brand Strategy: The EpiPen Controversy
In 2016, a major pharmaceutical product became the center of public outrage when its manufacturer implemented a controversial pricing strategy. The price for this life-saving device increased by over 500% in just a few years, sparking debates about pharmaceutical ethics, pricing transparency, and patient access to essential medications. This case study has since become a classic example in medical product marketing and brand strategy discussions.
Which pharmaceutical company faced severe backlash for its EpiPen pricing strategy that increased the cost from approximately $100 to over $600 between 2009 and 2016?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Mylan (now part of Viatris)', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Pfizer', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Johnson & Johnson', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'AstraZeneca', 'is_correct': False} | 0 | 0% |